{"id":21838,"date":"2025-01-09T09:24:36","date_gmt":"2025-01-09T09:24:36","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/"},"modified":"2025-01-10T11:05:44","modified_gmt":"2025-01-10T11:05:44","slug":"reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/","title":{"rendered":"Reputation in the pharmaceutical industry, new challenges and opportunities"},"content":{"rendered":"

Reputation has become a key element for the success of the pharmaceutical industry. As highlighted in the \u201cRepTraks 2024 Pharma Report<\/em><\/a>\u201d, public perception<\/strong> is not just an indicator of image but a true strategic asset<\/strong> capable of influencing business outcomes and relationships with patients, regulators, and communities.<\/p>\n

Analyzing the RepTrak\u2019s 2024 Pharma Repor<\/strong>t, we aimed to highlight the opportunities and challenges the sector faces in further strengthening its social role and building trust with stakeholders.<\/p>\n

A gradual recovery of reputation<\/h2>\n

After being praised for its swift response to the COVID-19 pandemic, the pharmaceutical industry experienced a decline in global trust<\/strong>, with its reputation dropping to average levels in 2023 (69.4 points). However, 2024 marks a positive change: the global score has reached 70.2 points, entering the “strong” range. While this recovery is encouraging, it is not uniform: the data reveals significant disparities in markets<\/strong> like France and the United States, where recovery is slower due to fragile trust and issues related to high drug costs.<\/p>\n

Reputation drivers<\/h2>\n

The report identifies seven key drivers influencing the industry’s reputation: Leadership, Products and Services, Performance, Innovation, Conduct, Workplace Environment, and Citizenship. All these elements showed improvements in 2024, but certain areas require particular attention:<\/p>\n

    \n
  • Innovation<\/strong>: With a score of 72.3, innovation registered the most modest increase (+0.5). Stakeholder expectations, heightened by the extraordinary speed in developing COVID-19 vaccines, place significant pressure on the industry<\/strong>. Companies must demonstrate the ability to replicate this agility in other therapeutic areas, investing in advanced technologies and strategic collaborations<\/strong>.<\/li>\n
  • Conduct and Transparency<\/strong>: Despite a 1.4-point improvement, conduct remains the weakest driver (70.0). Stakeholders continue to demand greater ethics and transparency in operations<\/strong>, essential elements for consolidating credibility.<\/li>\n
  • Citizenship<\/strong>: The growing interest in the social contribution of pharmaceutical companies is reflected in the score of 70.8 (+1.6). The industry is called to play an active role in promoting global health<\/strong> by embracing sustainability initiatives and holistic well-being.<\/li>\n<\/ul>\n

    Stakeholders and business actions<\/h2>\n

    Reputation directly impacts stakeholder behavior. In 2024, the global score for key actions such as \u201cRecommending Products\u201d (70.6) and \u201cTrust in Doing the Right Thing\u201d (68.5) shows signs of recovery. However, the U.S. market remains a challenge, with a significantly lower trust score (64.7). To regain consumer trust, companies must communicate their values and commitments clearly<\/strong>, going beyond clinical results.<\/p>\n

    Strategies for the future<\/h2>\n

    The report suggests three key actions to strengthen long-term reputation:<\/p>\n

      \n
    1. Authenticity<\/strong>: Companies must demonstrate consistency between statements and actions, emphasizing their integrity.<\/li>\n
    2. Empowering Influencers<\/strong>: Engaging healthcare professionals and opinion leaders can amplify corporate messaging and reinforce positive perception.<\/li>\n
    3. Investments in Ethical Innovation<\/strong>: The use of advanced technologies must be accompanied by a responsible approach to balance scientific progress with respect for ethical principles.<\/li>\n<\/ol>\n

      The reputation of the pharmaceutical industry is not static but dynamic and closely tied to its ability to adapt to change. As shown by the \u201cRepTraks 2024 Pharma Report\u201d, investing in transparency, innovation, and social responsibility<\/strong> is crucial to ensuring long-term resilience. Only by addressing these challenges with a focused strategy can companies solidify their role as leaders in global health.<\/p>\n","protected":false},"excerpt":{"rendered":"

      After the peak of trust experienced during the pandemic, the pharmaceutical industry is now working to rebuild its global reputation. The “RepTraks 2024 Pharma Report” highlights the progress made and the critical issues that still need to be addressed, including innovation, transparency, and social responsibility.<\/p>\n","protected":false},"author":32,"featured_media":21829,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[788],"tags":[],"class_list":{"0":"post-21838","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-corporate-social-responsibility-en"},"yoast_head":"\nReputation in the pharma industry, challenges and opportunities<\/title>\n<meta name=\"description\" content=\""RepTraks 2024 Pharma Report": the pharmaceutical industry must strengthen its social role, balancing innovation and transparency.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reputation in the pharma industry, challenges and opportunities\" \/>\n<meta property=\"og:description\" content=\""RepTraks 2024 Pharma Report": the pharmaceutical industry must strengthen its social role, balancing innovation and transparency.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-09T09:24:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-10T11:05:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"headline\":\"Reputation in the pharmaceutical industry, new challenges and opportunities\",\"datePublished\":\"2025-01-09T09:24:36+00:00\",\"dateModified\":\"2025-01-10T11:05:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/\"},\"wordCount\":505,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg\",\"articleSection\":[\"Corporate Social Responsibility\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/\",\"name\":\"Reputation in the pharma industry, challenges and opportunities\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg\",\"datePublished\":\"2025-01-09T09:24:36+00:00\",\"dateModified\":\"2025-01-10T11:05:44+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"description\":\"\\\"RepTraks 2024 Pharma Report\\\": the pharmaceutical industry must strengthen its social role, balancing innovation and transparency.\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg\",\"width\":2560,\"height\":1706,\"caption\":\"Creative art collage of customer show smile face emoticon for rating. Service rating, satisfaction and positive feedback concept\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reputation in the pharmaceutical industry, new challenges and opportunities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reputation in the pharma industry, challenges and opportunities","description":"\"RepTraks 2024 Pharma Report\": the pharmaceutical industry must strengthen its social role, balancing innovation and transparency.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/","og_locale":"en_US","og_type":"article","og_title":"Reputation in the pharma industry, challenges and opportunities","og_description":"\"RepTraks 2024 Pharma Report\": the pharmaceutical industry must strengthen its social role, balancing innovation and transparency.","og_url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2025-01-09T09:24:36+00:00","article_modified_time":"2025-01-10T11:05:44+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"headline":"Reputation in the pharmaceutical industry, new challenges and opportunities","datePublished":"2025-01-09T09:24:36+00:00","dateModified":"2025-01-10T11:05:44+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/"},"wordCount":505,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg","articleSection":["Corporate Social Responsibility"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/","url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/","name":"Reputation in the pharma industry, challenges and opportunities","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg","datePublished":"2025-01-09T09:24:36+00:00","dateModified":"2025-01-10T11:05:44+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"description":"\"RepTraks 2024 Pharma Report\": the pharmaceutical industry must strengthen its social role, balancing innovation and transparency.","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/01\/AdobeStock_908082644-scaled.jpeg","width":2560,"height":1706,"caption":"Creative art collage of customer show smile face emoticon for rating. Service rating, satisfaction and positive feedback concept"},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/corporate-social-responsibility-en\/reputazione-nellindustria-farmaceutica-tra-nuove-sfide-e-opportunita\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Reputation in the pharmaceutical industry, new challenges and opportunities"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=21838"}],"version-history":[{"count":4,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21838\/revisions"}],"predecessor-version":[{"id":21842,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21838\/revisions\/21842"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/21829"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=21838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=21838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=21838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}